- Home
- FTLF vs MCRB Comparison
FTLF vs MCRB Comparison
Compare FTLF & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTLF
- MCRB
- Stock Information
- Founded
- FTLF 2005
- MCRB 2010
- Country
- FTLF United States
- MCRB United States
- Employees
- FTLF N/A
- MCRB N/A
- Industry
- FTLF Medicinal Chemicals and Botanical Products
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- FTLF Health Care
- MCRB Health Care
- Exchange
- FTLF Nasdaq
- MCRB Nasdaq
- Market Cap
- FTLF 149.3M
- MCRB 144.6M
- IPO Year
- FTLF N/A
- MCRB 2015
- Fundamental
- Price
- FTLF $20.03
- MCRB $19.70
- Analyst Decision
- FTLF Strong Buy
- MCRB Hold
- Analyst Count
- FTLF 2
- MCRB 4
- Target Price
- FTLF $23.00
- MCRB $14.33
- AVG Volume (30 Days)
- FTLF 15.8K
- MCRB 129.8K
- Earning Date
- FTLF 11-13-2025
- MCRB 11-12-2025
- Dividend Yield
- FTLF N/A
- MCRB N/A
- EPS Growth
- FTLF N/A
- MCRB N/A
- EPS
- FTLF 0.80
- MCRB 10.22
- Revenue
- FTLF $63,053,000.00
- MCRB N/A
- Revenue This Year
- FTLF $34.34
- MCRB N/A
- Revenue Next Year
- FTLF $48.58
- MCRB N/A
- P/E Ratio
- FTLF $25.03
- MCRB $1.89
- Revenue Growth
- FTLF 3.91
- MCRB N/A
- 52 Week Low
- FTLF $9.83
- MCRB $6.53
- 52 Week High
- FTLF $20.98
- MCRB $24.67
- Technical
- Relative Strength Index (RSI)
- FTLF 57.48
- MCRB 51.72
- Support Level
- FTLF $19.76
- MCRB $18.54
- Resistance Level
- FTLF $20.77
- MCRB $21.50
- Average True Range (ATR)
- FTLF 0.48
- MCRB 1.26
- MACD
- FTLF -0.11
- MCRB -0.14
- Stochastic Oscillator
- FTLF 25.35
- MCRB 29.97
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.